Laboratorios Farmaceuticos ROVI (ROVI) - Cash Flow Conversion Efficiency

Latest as of September 2025: 0.116x

Based on the latest financial reports, Laboratorios Farmaceuticos ROVI (ROVI) has a cash flow conversion efficiency ratio of 0.116x as of September 2025. Cash flow conversion efficiency measures how effectively a company's net assets (equity) generate operating cash flow. It is calculated by dividing operating cash flow (€73.37 Million ≈ $85.78 Million USD) by net assets (€632.80 Million ≈ $739.81 Million USD). A higher ratio indicates that the company is more efficient at using its equity to generate cash flow from its core operations. Also see ROVI stock market capitalisation for the company's overall valuation and market capitalisation.

Laboratorios Farmaceuticos ROVI - Cash Flow Conversion Efficiency Trend (2006–2024)

This chart illustrates how Laboratorios Farmaceuticos ROVI's cash flow conversion efficiency has evolved over time, based on yearly financial data.

Laboratorios Farmaceuticos ROVI Competitors by Cash Flow Conversion Efficiency

The table below lists competitors of Laboratorios Farmaceuticos ROVI ranked by their cash flow conversion efficiency. Explore Laboratorios Farmaceuticos ROVI (ROVI) cash flow quality to measure how well operating cash flow supports reported net income.

Company	Cash Flow Conversion Efficiency
Nuscale Power Corp NYSE:SMR	-0.029x
First Capital Real Estate Investment Trust TO:FCR-UN	0.008x
Constellium Nv NYSE:CSTM	0.128x
Canadian Apartment Properties Real Estate Investment Trust TO:CAR-UN	0.009x
CMB.TECH NV BR:CMBT	0.054x
Quálitas Controladora S.A.B. de C.V. MX:Q	0.103x
Hubei Jumpcan Pharmaceutical Co Ltd SHG:600566	-0.016x
Henan Huanghe Whirlwind Co Ltd SHG:600172	-0.034x

Annual Cash Flow Conversion Efficiency for Laboratorios Farmaceuticos ROVI (2006–2024)

The table below shows the annual cash flow conversion efficiency of Laboratorios Farmaceuticos ROVI from 2006 to 2024. View Laboratorios Farmaceuticos ROVI share price for real-time trading data and today's change.

Year	Net Assets	Operating Cash Flow	Cash Flow Conversion Efficiency	Change
2024-12-31	€581.54 Million ≈ $679.88 Million	€138.28 Million ≈ $161.66 Million	0.238x	+14.11%
2023-12-31	€543.49 Million ≈ $635.40 Million	€113.25 Million ≈ $132.40 Million	0.208x	-54.28%
2022-12-31	€521.38 Million ≈ $609.55 Million	€237.60 Million ≈ $277.78 Million	0.456x	+43.62%
2021-12-31	€470.98 Million ≈ $550.62 Million	€149.44 Million ≈ $174.71 Million	0.317x	+152.96%
2020-12-31	€373.70 Million ≈ $436.89 Million	€46.88 Million ≈ $54.80 Million	0.125x	+547.14%
2019-12-31	€322.39 Million ≈ $376.90 Million	€-9.04 Million ≈ $-10.57 Million	-0.028x	-194.53%
2018-12-31	€287.47 Million ≈ $336.08 Million	€8.53 Million ≈ $9.97 Million	0.030x	-68.47%
2017-12-31	€191.69 Million ≈ $224.10 Million	€18.04 Million ≈ $21.09 Million	0.094x	-62.09%
2016-12-31	€183.41 Million ≈ $214.42 Million	€45.53 Million ≈ $53.22 Million	0.248x	+39.17%
2015-12-31	€164.78 Million ≈ $192.65 Million	€29.39 Million ≈ $34.36 Million	0.178x	+22.88%
2014-12-31	€158.47 Million ≈ $185.27 Million	€23.00 Million ≈ $26.89 Million	0.145x	-29.67%
2013-12-31	€144.46 Million ≈ $168.89 Million	€29.82 Million ≈ $34.86 Million	0.206x	+33.06%
2012-12-31	€126.45 Million ≈ $147.83 Million	€19.61 Million ≈ $22.93 Million	0.155x	+39.39%
2011-12-31	€113.98 Million ≈ $133.26 Million	€12.68 Million ≈ $14.83 Million	0.111x	-45.31%
2010-12-31	€104.13 Million ≈ $121.74 Million	€21.19 Million ≈ $24.77 Million	0.203x	+51.20%
2009-12-31	€71.50 Million ≈ $83.59 Million	€9.62 Million ≈ $11.25 Million	0.135x	-48.51%
2008-12-31	€48.44 Million ≈ $56.63 Million	€12.66 Million ≈ $14.80 Million	0.261x	+1079.12%
2007-12-31	€51.92 Million ≈ $60.70 Million	€1.15 Million ≈ $1.35 Million	0.022x	-92.59%
2006-12-31	€25.81 Million ≈ $30.17 Million	€7.72 Million ≈ $9.02 Million	0.299x	--

About Laboratorios Farmaceuticos ROVI

MC:ROVI Spain Drug Manufacturers - Specialty & Generic

Market Cap

$3.46 Billion

€2.96 Billion EUR

Market Cap Rank

#4500 Global

#38 in Spain

Share Price

€57.85

Change (1 day)

+0.96%

52-Week Range

€53.65 - €85.55

All Time High

€90.54